Satraplatin and Prednisone to Treat Prostate Cancer

NCT00634647 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

24

Enrollment

NIH

Sponsor class

Conditions

Prostate Cancer
Genetic Polymorphism

Interventions

DRUG: Satraplatin
DRUG: prednisone

Sponsor

National Cancer Institute (NCI)